Healthcare Industry News: Elekta
News Release - January 24, 2008
Elekta: Procure Selects IMPAC as Provider of Oncology Information SystemsProCure Treatment Centers, Inc (ProCure) has announced that it has selected IMPAC Medical Systems (IMPAC), an Elekta Company (STO:EKTAB), as a preferred provider of oncology information systems (OIS) for its IBA-equipped proton beam therapy centers. ProCure designs, builds and operates proton beam therapy centers in partnership with local radiation oncologists and community hospitals.
STOCKHOLM, Sweden--(HSMN NewsFeed)--Regulatory News: A key component of developing proton beam therapy centers is the staffing and training of all the center’s employees. ProCure will have IMPAC’s MOSAIQ™ OIS software installed at its training and development center (TDC) in Bloomington, IN. IMPAC will provide training at the TDC for the staff of ProCure’s IBA-equipped proton therapy centers.
“ProCure’s training and development center will ensure that their staff is highly trained, efficient and ready to provide the highest level of care when a proton center opens,” said Stewart Pegrum, Global Business Manager Particle Therapy, at Elekta. “The TDC is the first facility dedicated to training the highly-skilled professionals needed for proton therapy. The availability of the MOSAIQ OIS system at the TDC will enable ProCure to both train personnel, and to optimize the therapy workflow of the ProCure treatment centers.”
Construction is underway on the Oklahoma ProCure Treatment Center in Oklahoma City, Oklahoma and the facility is expected to begin treating patients in the summer of 2009. The facility will utilize the MOSAIQ OIS software.
ProCure currently has a second facility in development in Chicago’s western suburbs; a certificate of need application is before the Illinois Healthcare Facilities Planning Board. If regulatory approvals are received by the spring of 2008, it is expected patients will be able to receive treatment by mid-2010.
The MOSAIQ software is currently deployed at the Francis Burr Proton Therapy Center at Massachusetts General Hospital, MD Anderson, University of Florida Proton Therapy Institute and the Midwest Proton Radiotherapy Institute. “The IMPAC team brings significant expertise in proton therapy and radiation oncology with their software solution and more importantly the associated service,” said Niek Schreuder, Senior Vice President of Technology at ProCure Treatment Centers. “Elekta and IMPAC share the ProCure vision of making the OIS the central hub for all the therapy workflow, and together we can make this happen. This will provide significant benefits to our physician partners, hospital partners and their patients,” added Schreuder.
Elekta is an international medical technology group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight serious disease.
Elekta provides advanced clinical solutions, comprehensive management and information systems as well as services for improved cancer care and management of brain disorders.
Elekta’s systems and solutions are used in over 4,500 hospitals around the world. Clinical and information management solutions include, among others, Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta Axesse™ and Elekta Synergy® for stereotactic and image guided radiation therapy and radiosurgery as well as the MOSAIQ™ suite of software for image-enabled EMR and efficient management of clinical and patient data.
With over 2,000 employees globally, the corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information about Elekta can be found at www.Elekta.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.